Lv41
748 积分 2021-10-29 加入
Efficacy and safety of a biased GLP-1 receptor agonist ecnoglutide in adults with overweight or obesity: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
4小时前
待确认
Herding in the drug development pipeline
5天前
已完结
Comparative Effectiveness of SGLT2 Inhibitors and GLP-1 Receptor Agonists in Preventing Alzheimer's Disease, Vascular Dementia, and Other Dementia Types Among Patients with Type 2 Diabetes
1个月前
已完结
GLP-1 Medications May Lower Dementia Risk, Research Shows
1个月前
已关闭
Neural correlates of liraglutide effects in persons at risk for Alzheimer’s disease
1个月前
已完结
GLP-1RA and SGLT2i Medications for Type 2 Diabetes and Alzheimer Disease and Related Dementias
1个月前
已完结
The evolution of the obesity drug market
1个月前
已完结
GLP-1R agonists protect against Alzheimer’s disease by rewiring energy regulation
1个月前
已完结
The evolution of the obesity drug market
1个月前
已完结
Human germline gain-of-function in STAT6: from severe allergic disease to lymphoma and beyond
2个月前
已完结
皖公网安备34019202002308
